PBE
Invesco Biotechnology & Genome ETF
ETF
$95.07−0.03 (−0.03%)Close Oct 2, 2026
Jun 23, 2005 – Oct 2, 2026, Dividends reinvested
- Final balance
- $68,180
- CAGR
- +9.44%
- Max drawdown
- −45.69%
- Sharpe ratio
- 0.48
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Annualized from 3Y- 1M
- −3.64%
- 3M
- +3.31%
- 6M
- +21.75%
- YTD
- +17.00%
- 1Y
- +34.15%
- 3Y
- +20.02%
- 5Y
- +5.44%
- 10Y
- +8.88%
- 15Y
- +11.98%
- 20Y
- +9.36%
- Since 2005
- +9.44%
Metrics
Since 2005| Volatility | 25.20% |
|---|---|
| Sortino ratio | 0.69 |
| Calmar ratio | 0.21 |
| Best year, 2013 | +62.22% |
| Worst year, 2008 | −26.75% |
| Positive years | 15 of 20 |
| Longest drawdown | 5 years |
Worst drawdowns
Since 2005| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −45.7% | Oct 2007 | Mar 2009 | Oct 2010 | 3 years |
| −44.6% | Jul 2015 | Jun 2016 | Jul 2020 | 5 years |
| −37.8% | Feb 2021 | Jun 2022 | Nov 2025 | 4.8 years |
| −26.4% | May 2011 | Aug 2011 | Jul 2012 | 1.1 years |
| −21.1% | Feb 2006 | Jul 2006 | Apr 2007 | 1.1 years |
Annual returns
2005 from Jun 23 · 2026 through Oct 2